Order Article Reprints

Gavriilaki E, Mallouri D, Bousiou Z, Demosthenous C, Vardi A, Dolgyras P, Batsis I, Stroggyli E, Karvouni P, Masmanidou M, et al. Molecular and Clinical Characteristics of Different Toxicity Rates in Anti-CD19 Chimeric Antigen Receptor T Cells: Real-World Experience. Cancers. 2023; 15(17):4253. https://doi.org/10.3390/cancers15174253

Gavriilaki, E., D. Mallouri, Z. Bousiou, C. Demosthenous, A. Vardi, P. Dolgyras, I. Batsis, E. Stroggyli, P. Karvouni, M. Masmanidou, and et al. 2023. "Molecular and Clinical Characteristics of Different Toxicity Rates in Anti-CD19 Chimeric Antigen Receptor T Cells: Real-World Experience" Cancers 15, no. 17: 4253. https://doi.org/10.3390/cancers15174253

Gavriilaki, E., Mallouri, D., Bousiou, Z., Demosthenous, C., Vardi, A., Dolgyras, P., Batsis, I., Stroggyli, E., Karvouni, P., Masmanidou, M., Gavriilaki, M., Bouinta, A., Bitsianis, S., Kapravelos, N., Bitzani, M., Vasileiadou, G., Yannaki, E., Sotiropoulos, D., Papagiannopoulos, S., ... Sakellari, I. (2023). Molecular and Clinical Characteristics of Different Toxicity Rates in Anti-CD19 Chimeric Antigen Receptor T Cells: Real-World Experience. Cancers, 15(17), 4253. https://doi.org/10.3390/cancers15174253